Neos, Teva settle litigation over ADHD drug

Neos Therapeutics Inc. entered into a confidential settlement and licensing agreement Wednesday with Teva Pharmaceuticals USA Inc. to resolve all ongoing litigation involving Neos' patents for its Cotempla product. The two companies got involved in litigation after Teva Pharmaceuticals USA of North Wales, Pa., filed an application with the Food and Drug Administration to market a generic version of the medicine used to treat attention deficit hyperactivity disorder. Under the settlement and license…
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news